Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TIRZEPATIDE
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- A Study of Tirzepatide (LY3298176) to Assess Glycemic Control in Adults With Type 2 Diabetes Switching From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- A Study of LY3457263 in Obese Participants
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
- The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
- A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
- Study of Tirzepatide in Healthy Participants
- A Study of Tirzepatide in Overweight and Very Overweight Participants
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- A Study to Measure Food and Calorie Consumption in Very Overweight Participants Using Tirzepatide
- A Study of Tirzepatide Concentrations at Different Injection Sites in Participants With Different Body Sizes
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
- A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- A Study of Tirzepatide in Participants With Impaired Liver Function
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- A Study of Tirzepatide (LY3298176) in Healthy Participants
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Clinical trials list
click for details